Core Viewpoint - Rosen Law Firm is reminding investors who purchased Red Cat Holdings, Inc. securities between March 18, 2022, and January 15, 2025, of the July 22, 2025, deadline to become a lead plaintiff in a class action lawsuit due to alleged misleading statements by the company [1][4]. Group 1: Class Action Details - Investors who purchased Red Cat securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties must move the Court by July 22, 2025, to serve as lead plaintiff [2]. - The lawsuit claims that Red Cat made false and misleading statements regarding its production capacity and the value of its contracts, leading to investor damages when the truth was revealed [4]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest settlement against a Chinese company at the time and being ranked No. 1 for securities class action settlements in 2017 [3]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [3]. - Founding partner Laurence Rosen has been recognized as a Titan of Plaintiffs' Bar by Law360, and many attorneys at the firm have received accolades from Lawdragon and Super Lawyers [3].

Core Viewpoint - A class action lawsuit has been filed against Iovance Biotherapeutics, Inc. for allegedly providing misleading information regarding its growth potential and operational capabilities during the class period from May 9, 2024, to May 8, 2025 [1][3]. Company Performance - Iovance announced its financial results for Q2 of fiscal 2024 on July 25, 2024, and subsequently reduced its revenue guidance for the full fiscal year 2024 due to several factors, including maintenance of its iCTC, lower-than-expected Proleukin sales, and the variable pace of treatment initiation at approved centers [4]. - Following the announcement, Iovance's stock price plummeted from $3.17 per share on May 8, 2025, to $1.75 per share on May 9, 2025, marking a decline of approximately 44.8% in just one day [4]. Legal Context - The class action lawsuit is on behalf of all individuals and entities that purchased Iovance securities during the specified class period, with a deadline of July 14, 2025, for investors to apply to be appointed as lead plaintiff [1]. - The lawsuit claims that the company made overwhelmingly positive statements while concealing material adverse facts about its ability to meet demand for its treatments [3]. Investor Information - Investors who suffered losses and wish to discuss their legal rights are encouraged to contact the law firm Bragar Eagel & Squire, P.C. for more information [5].

Core Viewpoint - A class action lawsuit has been filed against Strategy Incorporated (NASDAQ:MSTR) for allegedly making materially false and misleading statements regarding its business and operations during the Class Period from April 30, 2024, to April 4, 2025 [1][3]. Summary by Relevant Sections Lawsuit Details - The lawsuit is filed in the United States District Court for the Eastern District of Virginia on behalf of all individuals and entities who purchased or acquired Strategy securities during the specified Class Period [1]. - Investors have until July 15, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit [1]. Allegations Against the Company - The complaint alleges that the defendants made false and misleading statements about the anticipated profitability of the Company's bitcoin-focused investment strategy and treasury operations, which were overstated [3]. - It is claimed that the risks associated with bitcoin's volatility and potential losses on the value of digital assets were understated [3]. - As a result, the public statements made by the defendants were materially false and misleading throughout the Class Period [3]. Investor Information - Investors who suffered losses, are long-term stockholders, or have information related to the claims are encouraged to contact the law firm for more details [4].

Core Viewpoint - Investors in Reckitt Benckiser Group PLC have until August 4, 2025, to file lead plaintiff applications in a securities class action lawsuit due to alleged failures in disclosing material information during the Class Period from January 13, 2021, to July 28, 2024 [1][3]. Group 1: Lawsuit Details - The lawsuit alleges that Reckitt and certain executives failed to disclose material information, violating federal securities laws [3]. - Specific allegations include that preterm infants were at an increased risk of developing necrotizing enterocolitis (NEC) from consuming the company's cow's milk-based formula, Enfamil, which could impact sales and expose the company to legal claims [4]. - The lawsuit is titled Elevator Constructors Union Local No. 1 Annuity & 401(K) Fund v. Reckitt Benckiser Group PLC, et al., No. 25-cv-4708 [5]. Group 2: ClaimsFiler Information - ClaimsFiler is a free shareholder information service aimed at helping retail investors recover funds from securities class action settlements [6]. - The platform allows investors to register for free, access information on various securities class action cases, upload portfolio transactional data, and submit inquiries for free case evaluations [6].

Core Viewpoint - A securities class action lawsuit has been filed against MicroStrategy Incorporated, alleging that the company made materially false and misleading statements regarding its business and operations during the specified Class Period from April 30, 2024, to April 4, 2025 [1][2]. Group 1: Allegations Against MicroStrategy - The lawsuit claims that the anticipated profitability of MicroStrategy's bitcoin-focused investment strategy was overstated [2]. - It is alleged that the risks associated with bitcoin's volatility and potential losses on digital assets were understated [2]. - The complaint asserts that the public statements made by the defendants were materially false and misleading throughout the Class Period [2]. Group 2: Lead Plaintiff Process - Investors in MicroStrategy have until July 15, 2025, to seek appointment as a lead plaintiff representative of the class [3]. - A lead plaintiff acts on behalf of all class members and is typically the investor or group of investors with the largest financial interest [3]. - The lead plaintiff has the authority to select counsel to represent the class, subject to court approval [3]. Group 3: Law Firm Information - Kessler Topaz Meltzer & Check, LLP is encouraging investors who have suffered losses to contact them for more information [4]. - The firm has a reputation for prosecuting class actions and has recovered billions for victims of corporate misconduct [4].

NEW YORK, July 11, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Organon & Co. (NYSE: OGN) between November 3, 2022 and April 30, 2025, both dates inclusive (the "Class Period"), of the important July 22, 2025 lead plaintiff deadline.So what: If you purchased Organon securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.What to do next:  ...

NEW YORK, July 11, 2025 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of all persons or entities who purchased or otherwise acquired Centene Corporation (“Centene” or the “Company”) (NYSE: CNC) securities between December 12, 2024 and June 30, 2025, both dates inclusive (the “Class Period”). The Complaint alleges that Defendants created the false impression that ...

SAN DIEGO, July 11, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that the Centene class action lawsuit – captioned Lunstrum v. Centene Corporation, No. 25-cv-05659 (S.D.N.Y.) – seeks to represent purchasers or acquirers of Centene Corporation (NYSE: CNC) securities and charges Centene and certain of Centene’s executives with violations of the Securities Exchange Act of 1934. If you suffered substantial losses and wish to serve as lead plaintiff of the Centene class act ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Red Cat Holdings, Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline on July 22, 2025, for a class action lawsuit [1][2]. Group 1: Class Action Details - Investors who bought Red Cat securities between March 18, 2022, and January 15, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by July 22, 2025 [2]. Group 2: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest settlement against a Chinese company at the time and being ranked No. 1 for securities class action settlements in 2017 [3]. - The firm has recovered hundreds of millions of dollars for investors, securing over $438 million in 2019 alone [3]. Group 3: Case Allegations - The lawsuit alleges that Red Cat Holdings made false and misleading statements regarding the production capacity of its Salt Lake City Facility and the value of the SRR Program's Tranche 2 contract, leading to investor damages when the truth was revealed [4].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Red Cat Holdings, Inc. regarding a class action lawsuit due to alleged misleading statements and omissions made by the company during a specified class period [1][3]. Summary by Relevant Sections Class Period and Allegations - The class period for the lawsuit is from March 18, 2022, to January 15, 2025 [3]. - Allegations include that the company overstated the production capacity of the Salt Lake City Facility and the value of the U.S. Army's Short Range Reconnaissance Program of Record Tranche 2 contract, leading to materially false and misleading public statements [3]. Next Steps for Shareholders - Shareholders are encouraged to register for the class action by July 22, 2025, to potentially be appointed as lead plaintiffs [4]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the case's progress [4]. Law Firm's Mission - The Gross Law Firm aims to protect investors' rights against deceit and fraud, ensuring companies adhere to responsible business practices [5].